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Abstract—The purpose of this study was to investigate the 
long-term visual dysfunction in patients after blast-induced 
mild traumatic brain injury (mbTBI) using a retrospective case 
series of 31 patients with mbTBI (>12 mo prior) without eye 
injuries. Time since mbTBI was 50.5 +/– 19.8 mo. Age at the 
time of injury was 30.0 +/– 8.3 yr. Mean corrected visual acu-
ity was 20/20. Of the patients, 71% (n = 22) experienced loss 
of consciousness; 68% (n = 15) of patients in this subgroup 
were dismounted during the blast injury. Overall, 68% (n = 21) 
of patients had visual complaints. The most common com-
plaints were photophobia (55%) and difficulty with reading 
(32%). Of all patients, 25% were diagnosed with convergence 
insufficiency and 23% had accommodative insufficiency. 
Patients with more than one mbTBI had a higher rate of visual 
complaints (87.5%). Asymptomatic patients had a significantly 
longer time (62.5 +/– 6.2 mo) since the mbTBI than symptom-
atic patients (42.0 +/– 16.4 mo, p < 0.004). Long-term visual 
dysfunction after mbTBI is common even years after injury 
despite excellent distance visual acuity and is more frequent if 
more than one incidence of mbTBI occurred. We recommend 
obtaining a careful medical history, evaluation of symptoms, 
and binocular vision assessment during routine eye examina-
tions in this prepresbyopic patient population.
Key words: accommodative insufficiency, blast-induced trau-
matic brain injury, combat-related traumatic brain injury, con-
vergence insufficiency, dismounted injury, eyes, loss of 
consciousness, mild traumatic brain injury, near vision deficit, 
photophobia, traumatic brain injury, visual dysfunction.
INTRODUCTION
The Department of Defense reports that over 250,000 
servicemembers have been diagnosed with traumatic 
brain injury (TBI) since the conflicts in Afghanistan 
(2001–present) and Iraq (2003–2011) began [1]. Among 
deployed servicemembers, the average rate of newly 
diagnosed TBI has been 542 cases per month over the 
past 5 yr [2]. Mild TBI (mTBI) accounts for 77 percent of 
all cases over the past decade and is characterized by the 
following symptoms at the time of the trauma: loss of 
consciousness (LOC) for up to 30 min or an alteration in 
mental state and/or memory loss for less than 24 h [1]. 
The natural history of mTBI has been described to be 
self-limited with a predictable course [3]. Most symp-
toms of mTBI resolve within 6 mo, and only a small sub-
set of patients have persistent symptoms up to 1 yr [3–5].
However, in a recent study of U.S. servicemembers 
with combat-related mTBI, mostly blast explosion 
induced, subjects were found to still meet the criteria for 
postconcussion disorder up to 5 yr after their baseline 
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examination [6]. Blast-induced TBI, which is considered 
the signature injury for servicemembers deployed to Iraq 
and Afghanistan, is thought to be more complex than 
focal TBIs from sports concussions commonly observed 
in the civilian population [7]. The mechanisms of the pri-
mary injury from exposure to the shockwave are not well 
understood, but the ensuing shear forces seem to play an 
important role in the mechanism of blast-induced cellular 
and axonal injury, which is typically anatomically more 
diffusely and evenly distributed than a focal injury [7–11].
Previously, Wilk et al. reported that among service-
members with mTBI who reported LOC, blast mecha-
nism of injury was significantly associated with 
symptoms such as memory problems, dizziness, sensitiv-
ity to light, and headaches 3 to 6 mo postdeployment 
compared with a nonblast mechanism [12]. Lew et al. 
noted a high percentage of self-reported vision problems, 
photophobia, and oculomotor dysfunction during vision 
screening examinations of patients with predominantly 
mTBI [13]. Cockerham et al. described the early effect of 
blast-induced TBI without direct eye injury on the visual 
system [14]. Findings included visual field defects, 
decrease in contrast sensitivity, and hidden ocular injuries 
from blunt trauma despite good visual acuity. Stelmack et 
al. and Brahm et al. both reported visual problems and 
high rates of accommodative and convergence insuffi-
ciency in retrospective studies of patients with blast-
induced TBI in subacute settings [15–16]. Brahm et al.’s 
study included patients with mTBI of blast and non blast 
mechanisms [16], whereas Stelmack et al. did not report 
the degree of TBI [15]. A more recent study found signif-
icant visual dysfunction in servicemembers 45 to 60 d 
after blast-induced mTBI (mbTBI) compared with 
deployed controls without TBI [17]. However, none of 
these studies present long-term results in patients without 
direct eye injuries. Recognizing chronic visual symptoms 
and dysfunction in this young patient population is cru-
cial for successful intervention and reintegration into the 
civilian work force and society. In the present study, we 
researched whether visual symptoms and ocular dysfunc-
tion are present more than 12 mo after mbTBI in veterans 
without eye injuries.
METHODS
All patients with the diagnosis of mbTBI longer than 
12 mo prior to the eye examination and no history of eye 
injury before, during, or after the mbTBI who presented 
to the Washington DC Department of Veterans Affairs 
(VA) Medical Center (VAMC) eye clinic between January 
1, 2009, and December 31, 2011, were included in this 
retrospective study, and their electronic medical records 
were reviewed. Exclusion criteria included any other cate-
gory than mbTBI and any injury after deployment. Con-
firmation of the diagnosis and date of mbTBI was 
obtained from the second TBI evaluation examination 
performed by the polytrauma service and documented in 
the medical record. Date of injury, mechanism of injury 
(mounted vs dismounted, LOC), age at injury, time since 
injury, medications, visual symptoms, visual acuity, 
employment status, and documented eye examination 
results were reviewed and analyzed. In two patients, only 
the month and year of the injury were documented in the 
medical record. Therefore, the 15th day of the corre-
sponding month was entered for calculation of the time 
since the injury.
Cover testing was performed in primary gaze at dis-
tance and near. Distance visual acuity was measured 
using the projected Snellen eye chart. Accommodative 
insufficiency was diagnosed when the lower limit of the 
expected value for the patient’s age was abnormal 
according to Hofstetter’s formula [18]. Convergence 
insufficiency was diagnosed when there was exophoria 
greater at near compared with distance, an abnormal near 
point of convergence (NPC), and positive fusional ver-
gence. NPC measures the ability to maintain binocularly 
with increased accommodative and vergence demand. 
NPC was measured with the red lens method. A red lens 
was placed in front of patient’s right eye and the muscle 
light was moved close to the patient until the break (two 
lights) was reported or a break in fusion was observed by 
the examiner. A remote NPC with a break of greater than 
8 cm and recovery greater than 12 cm was considered 
abnormal [18].
STATISTICAL ANALYSIS
Mean and standard deviation values were calculated 
using SAS version 9.3 (SAS Institute Inc; Cary, North 
Carolina) and Graphpad Prism software version 4.0 
(GraphPad Software Inc; La Jolla, California). Mean 
visual acuity of the right and left eye of each patient was 
used to calculate the total mean visual acuity. The 
unpaired, two-tailed t-test was used to compare the time 73
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since injury between groups. Subgroup analysis was per-
formed using the Fisher test for patients without symp-
toms and not taking any medications and to evaluate 
LOC and a dismounted mechanism of injury.
RESULTS
From January 2009 to December 2011, a total of 192 
patients with the diagnosis of TBI presented to the Wash-
ington DC VAMC eye clinic for examinations. Of these 
patients, 31 experienced mbTBI without eye injury dur-
ing the conflicts in Iraq or Afghanistan and were included 
in the study. The majority of patients were male (94%) 
and the mean age at the time of injury was 30.5 ± 8.3 yr. 
Only 54 percent of the patients actively reported a history 
of TBI in their past medical history during the eye exam-
ination. However, documentation of mbTBI in the sec-
ondary TBI assessments performed by the polytrauma 
service at our VAMC were available in the electronic 
medical record. Of these patients, 18 (58%) were dis-
mounted (on the ground) during the injury, whereas 13 
(42%) were inside a military vehicle during the injury. 
Three patients had refractive surgery prior to their 
deployment.
The mean time interval between the mbTBI and docu-
mented eye examination was 50.5 ± 19.8 mo (range: 16–
91 mo). All patients had a mean best-corrected visual acu-
ity of 20/20 (logMar 0). Of the 31 patients, 27 (87%) were 
employed in full-time positions, whereas 4 (13%) were 
unemployed.
Two patients above 40 yr of age were diagnosed with 
physiologic presbyopia. To avoid bias in the analysis, 
their near vision complaints were excluded from the data 
analysis.
There was no documented evidence of anterior seg-
ment inflammation or any other abnormalities on slit 
lamp examination. Dilated examination revealed an old 
atrophic hole in the retinal periphery of one patient.
Visual Symptoms
Visual complaints were found in 68 percent (n = 21) 
of patients (Table 1). They were as follows: 55 percent 
reported problems with photophobia, 32  percent with 
reading and near work, 19 percent with floaters, 13 per-
cent with diplopia, and 3  percent with pain above the 
eyes. Ten patients (32%) had no visual complaints. 
Patients with more than one mbTBI (n = 8) had a higher 
rate of visual problems (87.5%) than patients with only 
one reported mbTBI (61%) but the difference was not 
statistically significant (p < 0.22). Asymptomatic patients 
had significantly longer time (62.5 ± 6.2 mo) since the 
mbTBI than symptomatic patients (41.8 ± 16.4 mo, p < 
0.004, unpaired t-test) (Figure). No patients reported 
visual symptoms 70 mo after mbTBI.
Photophobia
The most frequent complaint was light sensitivity, 
which was present in 55 percent of patients and ranged 
from mild to moderate as described by the patients. For 
alleviation of their symptoms, all patients with photopho-
bia received “wraparound” framed glasses with polarized 
lenses tinted with light transmission according to the 
patient’s preference for optimal comfort.
Three patients had undergone refractive surgery 
before deployment (two LASIK and one photorefractive 
keratectomy [PRK]). One of the LASIK patients was not 
symptomatic. His mbTBI occurred 61 mo prior to the eye 
examination and he was inside a vehicle during the 
explosion, possibly altering the impact of the blast. The 
other two patients complained of photophobia. Both were 
dismounted during the blast and were on no medications 
at the time of the eye examination. The time since injury 
was 18 mo for the PRK patient and 42 mo for the LASIK 
patient.
Near Vision Dysfunction
On eye examination, eight (25%) patients were diag-
nosed with convergence insufficiency and seven (23%) 
had accommodative insufficiency. The average NPC in 
patients diagnosed with convergence insufficiency was 
29.2 ± 24.0 cm (normal range: 2.5 ± 2.5 cm). Of the 
patients who were unemployed (n = 4), 75 percent were 
diagnosed with accommodative insufficiency and/or con-
vergence insufficiency, compared with only 33 percent of 
employed patients (n = 27). All patients with accommo-
dative insufficiency were given reading and computer 
glasses.
Loss of Consciousness
Of the patients, 22 (71%) experienced LOC and 9 
(29%) had an alteration of mental state without LOC 
(Table 1). Patients who experienced LOC did not experi-
ence more visual symptoms (64%) than patients who only 
had an altered mental status (78%, p < 0.67). Subgroup 
analysis showed that patients who were dismounted Group n (%)*
Time Since 
mbTBI, mo
(mean ± SD)
LOC
n (%)†
1 mbTBI
n (%)†
 >1 mbTBI
n (%)†
Presence of 
Visual Symptoms
n (%)†
All Patients 31 (100.0) 50.5 ± 19.8 22 (71) 24 (77) 8 (26) 21 (68)
1 mbTBI 23 (74.2) 48.4 ± 21.9 19 (83) 23 (100) — 14 (61)
>1 mbTBI 8 (25.8) 48.9 ± 12.9 6 (75) — 8 (100) 7 (88)
Dismounted Injury 18 (58.0) 41.8 ± 17.9 15 (83) 13 (72) 5 (28) 14 (78)
Vehicle Injury 13 (41.9) 54.1 ± 20.8 7 (54) 10 (77) 3 (23) 7 (54)
LOC 22 (70.9) 45.7 ± 19.9 22 (100) 16 (73) 6 (27) 14 (64)
Patient Not Taking
Medications
17 (54.8) 49.0 ± 22.6 14 (82) 17 (100) 0 (0) 10 (59)
No Medications:
Dismounted Injury
11 (35.5) 46.2 ± 24.4 9 (82) 11 (100) 0 (0) 8 (73)
No Medications:
Vehicle Injury
6 (18.3) 54.0 ± 20.0 1 (17) 6 (100) 0 (0) 2 (33)
Patient Taking
Medications
14 (45.2) 47.9 ± 16.5 7 (50) 7 (50) 7 (50) 11 (79)
With Medications:
Dismounted Injury
8 (25.8) 42.5 ± 14.1 7 (88) 3 (38) 5 (63) 6 (75)
With Medications:
Vehicle Injury
7 (22.5) 54.1 ± 16.7 2 (29) 4 (57) 3 (43) 5 (72)
Group
Photophobia 
n (%)†
Problems with 
Near Vision
n (%)†
Diplopia
n (%)†
Accommodative 
Insufficiency
n (%)†
Convergence 
Insufficiency
n (%)†
Floaters
n (%)†
All Patients 17 (55) 10 (32) 4 (13) 7 (23) 8 (25) 6 (19)
1 mbTBI 11 (61) 7 (39) 4 (17) 4 (22) 6 (33) 4 (22)
>1 mbTBI 6 (46) 6 (46) 0 (0) 3 (23) 2 (15) 2 (15)
Dismounted Injury 10 (45) 8 (36) 3 (17) 4 (18) 6 (22) 4 (18)
Vehicle Injury 10 (59) 6 (35) 1 (8) 4 (23) 4 (24) 2 (11)
LOC 7 (64) 4 (36) 3 (14) 3 (27) 3 (27) 1 (9)
Patient Not Taking
Medications
8 (47) 6 (35) 2 (12) 4 (24) 4 (24) 2 (12)
No Medications:
Dismounted Injury
7 (64) 5 (45) 2 (18) 3 (21) 4 (29) 4 (29)
No Medications:
Vehicle Injury
1 (17) 2 (33) 0 (0) 1 (17) 1 (17) 1 (17)
Patient Taking
Medications
9 (64) 7 (50) 2 (14) 3 (21) 4 (29) 4 (29)
With Medications:
Dismounted Injury
5 (63) 3 (38) 1 (13) 1 (13) 3 (38) 3 (38)
With Medications:
Vehicle Injury
5 (71) 4 (57) 1 (14) 2 (29) 1 (14) 1 (14)
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Table 1.
Visual symptoms after blast-induced mild traumatic brain injury (mbTBI).
*Percent of subgroup number of patients relative to total number of patients.
†Percent of subgroup number of patients with given symptom.
LOC = loss of consciousness, SD = standard deviation.75
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during the exposure to the 
Figure.
Patients with and without visual symptoms and time since 
blast-induced mild traumatic brain injury (mbTBI).
blast had more symptoms 
(78%) than patients who were inside a vehicle (54%) dur-
ing the explosion, but the difference was not statistically 
significant (p < 0.24). In addition, patients who were 
involved in a dismounted mechanism of blast injury (n = 
18) had the highest percentage (82%, n = 15) of LOC of 
all subgroups (Table 1).
Medication Use
Table 2 lists the medications used by 14 of the 
patients in the current study. Patients who did not take any 
medications (n = 17) had fewer visual symptoms (59%) 
than patients on medications (n = 14, 79%), but the differ-
ence was not found to be statistically significant (p < 
0.45, Fisher test). A significantly higher rate of patients 
who experienced LOC with a dismounted mechanism 
were taking medications (88%) compared with patients 
with LOC from an injury while inside a vehicle (29%, p < 
0.04). Similarly, a higher percentage of patients with 
more than one episode of mbTBI was on medications 
(88%) compared with patients who experienced only one 
mbTBI (30%, p < 0.01).
DISCUSSION
It is estimated that nearly half of all injured service-
members in Operation Enduring Freedom and Operation 
Iraqi Freedom were injured by explosive devices and 
experienced neurotrauma [7]. Blast-induced TBI is being 
widely studied, but its long-term effect on the visual sys-
tem remains unknown. Observations suggest that the 
mechanism by which explosive blast injuries damage the 
central nervous system may be more diffuse and evenly 
distributed throughout the brain than initially assumed 
[8–9]. Many factors influence the degree of a primary 
blast injury, including the distance to the detonation and 
whether the explosion occurred within an enclosed struc-
ture, because the latter can reflect the shockwave and 
increase both exposure time and tissue damage [19–21]. 
The human eye, with its dual cameral system and delicate 
structures, may be vulnerable to blast-wave and shear-
force injury, even when there is no obvious direct trauma 
to the eye. Previously, Cockerham et al. reported occult 
ocular damage in patients after blast exposure [14]. 
Brahm et al. published a retrospective study describing 
significant visual dysfunction of a large number of ser-
vicemembers in acute and subacute phases of rehabilita-
tion [16]. These authors also found a high rate of visual 
impairment and near-work related deficiencies in their 
patient population despite relatively normal visual acuity 
and normal visual fields. Later studies report that veter-
ans with blast-induced TBI with auditory deficits are 
likely to also have visual disturbances and vice versa 
[22–23]. Since the auditory and visual organs have fluid 
levels, they are more likely to be affected by an explosive 
blast wave.
We found evidence that the visual dysfunction and 
symptoms in these patients persist for a much longer time 
period than previously reported. Typically, a normal dis-
tance visual acuity presumes a healthy visual system in 
young patients. Our data highlights abnormalities of the 
visual system after mbTBI in a young patient population 
with excellent vision, despite the fact that our study has a 
retrospective design and a small sample size. Limitations 
of the study are that no computed tomography scan was 
obtained at the time of original injury, which may be diffi-
cult to achieve for mTBI in the war zone. Only patients 
who reported reading problems or were in the presbyopic 
age range were routinely evaluated for near vision deficits. 
Therefore, no data are available on the incidence of accom-
modative and convergence insufficiency in asymptomatic 
patients. Also, since patients came in for routine examina-
tions, no visual field testing was performed. However, all 
our patients were exposed to one or more blast explosions 
in the war zone and at that time developed symptoms that Medication
Total 
Patients
(n)
Indication
Photophobia
(n)
Near Vision 
Problems
(n)
Accommodative 
Insufficiency
(n)
Convergence 
Insufficiency
(n)
Time 
Since 
TBI (mo)
 >1 
mbTBI 
(n)
Sertaline 4 Depression 3 2 0 1 36.2 2
Nortryptiline 2 Depression 1 2 1 0 32.5 1
Hydrocodone/
Acetaminophen
1 Pain 0 1 0 1 27 1
Tramadol 1 Pain 1 0 0 0 46 0
Ibuprofen 1 Pain 1 1 1 1 38 1
Naproxen 6 Pain 5 1 0 1 42.5 1
Meloxicam 1 Anti-Inflammatory 0 0 0 0 44 1
Methocarbamol 1 Muscle Relaxation 1 0 0 1 43 0
Cyclobenzaprine 1 Muscle Relaxation 0 0 0 0 44 1
Amlodipine 1 Hypertension 0 0 0 0 77 1
Prazosin 2 Hypertension 0 0 0 0 46 2
Meclizine 1 Motion Sickness 1 0 0 0 47 1
Quetiapine 1 PTSD 2 0 0 1 68 1
Vardenafil 2 Erectile Dysfunction 1 1 0 2 43 0
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were consistent with mTBI. None of our patients had a his-
tory of any other trauma before, during, or after their 
deployments.
Our study also highlights that ocular motor abnor-
malities, which are often present in the early stages after 
TBI, may still affect patients years after the blast injury 
despite excellent vision. The rate of convergence insuffi-
ciency has been reported to be about 3 to 5 percent in the 
general population and 9 percent in civilian patients after 
TBI, which is three- to fivefold lower than the rate of 
25 percent in our study population [24–25].
In the current study, sensitivity to light was the most 
commonly reported ocular symptom. Although photo-
phobia in the absence of ocular inflammation is a com-
mon symptom described after TBI, the exact mechanism 
remains unknown [14–16,26–28]. Bohnen et al. showed 
that tolerance to light and sound decreased in patients 
6 mo after mTBI compared with control subjects and 
suggested that the cause was a cortical and subcortical 
lack of inhibitory control [27]. Nonuniform cortical excit-
ability has also been described in other brain disorders 
associated with photophobia, such as migraines and epi-
lepsy [29–32] A cortical hyperresponsitivity could inter-
fere with visual perception, leading to photophobia. The 
trigeminal nerve and its nuclei are the primary mediators 
of pain sensation in the eye and the ocular structures are 
densely innervated with trigeminal fibers [28]. During the 
explosion, an overpressure wave passes through the 
organs, including the eye, and the cytostructures may be 
affected [19]. A possible trigeminal trigger in these 
patients could be caused by light entering the eye. Further 
research is needed to elucidate the complex pathogenesis 
of this common complaint after TBI.
Medication intake was previously discussed as a con-
tributing factor for visual symptoms; for example, it is 
known that the medications used for depression, pain, 
and posttraumatic stress syndrome can have side effects 
on the visual system [17,33]. In the present study, 
patients who were on medications had higher percentages 
of visual symptoms than nonmedicated patients, but the 
difference between groups was not statistically signifi-
cant (p < 0.2) (Table 1). In addition, 59 percent of the 
patients in the current study who were not on medications 
still had visual symptoms, and 24  percent of these 
patients had accommodative insufficiency and/or conver-
gence insufficiency. This indicates that while side effects 
from certain medications can aggravate some of the 
visual symptoms typically associated with mbTBI, other 
causes for the visual dysfunction need to be considered in 
this patient population.
In our study, patients with LOC had a higher percent-
age of photophobia and accommodation and convergence 
insufficiency than patients without LOC (Table 1). A dis-
mounted mechanism of injury combined with LOC 
resulted in a significantly higher percentage of medication 
intake. Similarly, patients with more than one mbTBI had 
the highest rate of visual complaints, and a significantly 
higher percentage of those patients needed medication 
Table 2.
List of medications used by 14 of 31 patients and reported visual symptoms.
mbTBI = blast-induced mild traumatic brain injury, PTSD = posttraumatic stress disorder, TBI = traumatic brain injury.77
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therapy compared with patients who experienced a single 
mbTBI (Table 1). However, in our retrospective study, the 
small number of patients who experienced more than one 
mbTBI limits statistical power.
In a recent study, Iraq combat veterans with more than 
one episode of mbTBI were found to have decreased cere-
brocerebellar metabolic rates than controls without trauma 
[34]. This could explain the prolonged recovery in these 
patients. Our findings are consistent with previous reports 
of a cumulative effect after multiple TBIs resulting in 
increased postconcussive symptoms, although we highlight 
its effect on the visual system in this disorder [35–36].
An encouraging finding in the present study is the fact 
that visual symptoms were significantly less in patients 
who had more time since the combat-related mbTBI. In 
our study, no visual complaints were documented in 
patients who presented 70 mo after the mbTBI.
Most of our patients were in their third decade of life 
and gainfully employed. It is likely that the majority of 
the 250,000 servicemembers diagnosed with TBI once 
separated from the military will enter the civilian work-
force. The first 5 yr after leaving the military are crucial 
for veterans to transition into a productive civilian life, 
and early recognition of visual dysfunction may improve 
successful reintegration into society. Occult visual prob-
lems may affect veterans’ career choices negatively in 
addition to the frequent psychological and physical com-
bat-related visible and invisible injuries they may have 
endured. The current literature discusses that the symp-
toms of mbTBI can overlap with posttraumatic stress dis-
order (PTSD) or that both may be concurrently present 
after serving in the war zone [21,37–38]. Patients with 
PTSD were reported to have sensitivity to light, blurred 
vision, dry eye syndrome, and vision-related side effects 
from medication therapy; however, no prospective stud-
ies have been published to evaluate visual health in this 
patient population [39–41]. Ocular motility problems 
such as accommodative and convergence insufficiency, 
which cause visual symptoms, are more likely to stem 
from organic brain disease and may be helpful in separat-
ing PTSD and ophthalmic problems in selected cases.
Employed patients may present to non-VA ophthal-
mologists and optometrists for eye examinations. We sug-
gest asking these young patients whether they served in 
the military and have had a history of combat-related TBI, 
because only 54  percent of the patients in our study 
actively reported a past medical history of mbTBI during 
the eye examinations. Ideally, the NPC, extraocular motil-
ity, monocular accommodative testing, and distance and 
near cover tests should be conducted in all patients with 
the diagnosis of mbTBI in order to evaluate for accommo-
dative and convergence insufficiency. At a minimum, a 
simple screening test even the busiest provider should be 
able to perform during routine eye examinations is to 
assess the NPC. If the test is abnormal, then a more formal 
evaluation for binocular dysfunction is warranted. Recog-
nition of the visual problems and treatment with computer 
and reading glasses, prisms, and tinted lenses for photo-
phobia can be helpful in decreasing the patient’s symp-
toms and improving the quality of life. In selected cases, 
vision therapy can also be offered, where available.
Our study reinforces that unrecognized visual prob-
lems may go unnoticed for years and are often not appro-
priately addressed. Based on recent literature reports, 
evidence is mounting that symptoms associated with 
combat-related postconcussion disorder in servicemem-
bers can persist much longer than expected, and extended 
monitoring may be necessary in patients with chronic 
medical problems after TBI [6,36,39] A coordinated mul-
tidisciplinary effort between specialties, including oph-
thalmology and optometry, is needed to monitor and 
recognize persistent problems in these young veterans.
CONCLUSIONS
In summary, chronic visual dysfunction and symp-
toms are frequently present in veterans even years after 
mbTBI despite excellent distance visual acuity. Symp-
toms appear to improve 5 to 6 yr after injury and are 
more frequent if more than one episode of TBI was pres-
ent or if the patient was dismounted at the time of injury. 
Assessment of symptoms and binocular vision testing in 
this prepresbyopic patient population should be routinely 
performed during eye examinations to recognize visual 
problems. Future studies are needed to evaluate in more 
detail the effect of blast injuries on the visual system of 
exposed patients.
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